Instalab

Scallop IgE Test

The clearest blood signal of whether your immune system is primed to react to scallops.

Should you take a Scallop IgE test?

This test is most useful if any of these apply to you.

Reacted After Eating Seafood
You had hives, swelling, or breathing symptoms after a seafood meal and want to know if scallops were the trigger.
Already Allergic to Other Shellfish
You know you react to shrimp, crab, or lobster and want to see if scallops carry the same risk before your next meal.
Introducing Seafood to a Child
Family history of shellfish allergy has you cautious about first exposures, and you want data before the first bite.
Frequent Seafood Eater With New Symptoms
You eat shellfish often and recently started reacting, and you need to narrow down which species is the culprit.

About Scallop IgE

You had a reaction after eating scallops, or maybe just after a seafood meal where scallops were on the plate. You want to know whether scallops were the culprit, whether you can safely eat them again, and whether this means you need to avoid other shellfish too. This blood test gives you a concrete piece of that puzzle.

Scallop IgE (scallop-specific immunoglobulin E) measures antibodies your immune system has made against scallop proteins. A detectable level confirms your body has been sensitized. What it does not confirm, on its own, is whether you will actually react when you eat scallops. That distinction is everything.

What Scallop IgE Actually Measures

IgE is the antibody class your immune system uses to flag things it treats as threats. When you have scallop IgE in your blood, it means specialized immune cells have already learned to recognize scallop proteins and have prepared a rapid response. In a true allergic reaction, these antibodies signal mast cells and basophils to release histamine and other chemicals, which produces symptoms within minutes.

Scallops belong to the mollusk (bivalve) family, part of the broader shellfish allergy group that also includes mussels, oysters, and clams. The dominant protein driving most shellfish IgE reactions is called tropomyosin, a muscle protein shared across crustaceans and mollusks. This shared protein is why someone allergic to shrimp often reacts to scallops, and vice versa.

Sensitization Is Not the Same as Allergy

This is the most important thing to understand about any food-specific IgE result. A positive scallop IgE means your immune system recognizes scallop proteins. It does not automatically mean you will have a clinical reaction when you eat scallop. Many people have detectable food-specific IgE without ever experiencing symptoms.

In a large Italian multicenter study of 247 shrimp-allergic adults, patients who could safely eat mollusks often had measurable IgE to mollusk extracts anyway, and specific IgE levels to oyster and scallop did not differ significantly between those who reacted and those who tolerated the food. Current scallop IgE tests detect the immune pattern but cannot reliably predict the outcome on their own. Your clinical history, and sometimes a supervised food challenge, is what closes the gap.

Cross-Reactivity With Other Shellfish

If you are already known to react to shrimp, crab, or lobster, your scallop IgE result carries extra weight. Tropomyosin is highly conserved across shellfish species, so antibodies trained on one creature often recognize the others. In shrimp-allergic patients, allergy to mollusks is associated with IgE reactivity to extracts of mussel, oyster, clam, and scallop, and higher shrimp and tropomyosin IgE levels are linked to a higher chance of reacting to mollusks.

The reverse is also worth knowing. If scallop IgE is detectable, other shellfish tests often come back positive too. That does not prove clinical allergy to every species, but it does mean the full shellfish picture matters for decisions about what to eat and what to avoid.

Reference Ranges and Interpretation

Scallop IgE is reported in kilounits of allergen-specific antibody per liter (kUA/L). Clinical decision points that reliably predict reaction versus tolerance have been established for foods like shrimp, crab, and cod in specific populations, but scallop-specific cutoffs have not been validated to the same degree. Treat the categories below as orientation, not as universal targets. Your lab may use slightly different cutpoints depending on the assay.

CategoryTypical Interpretation
UndetectableNo measurable scallop-specific antibodies. Sensitization unlikely.
Low detectableSome antibody recognition present. May reflect cross-reactivity from other shellfish or shared proteins, without necessarily meaning clinical allergy.
ModerateMeaningful sensitization. Combined with a reaction history, supports a working diagnosis.
HighStrong sensitization. Higher levels generally increase the likelihood of clinical reactivity, though they do not guarantee it.

Compare your results within the same lab over time for the most meaningful trend. A result that moves from undetectable to clearly positive is more informative than a single borderline number from one draw.

When Results Can Be Misleading

A few situations distort scallop IgE results or make them harder to interpret:

  • Dust mite or cockroach sensitization: these allergens share tropomyosin with shellfish, and patients with perennial respiratory allergies to mites or cockroaches can produce positive shellfish IgE results without ever reacting to scallops clinically.
  • Recent high shellfish exposure: repeated exposure to shrimp or related shellfish can keep antibody levels elevated even if scallop itself is tolerated.
  • Assay differences: scallop IgE may be measured on different platforms, and results from one system do not always translate directly to another. Stay with one lab when tracking your number over time.
  • Low-level positives in tolerant people: sensitization without clinical allergy is common. A detectable result alone, in someone who eats scallops without symptoms, usually does not warrant avoiding them.

Tracking Your Trend

Scallop IgE is not a one-shot verdict. Levels can rise with repeated exposure, fall over years of avoidance, or shift with immunotherapy. A single reading tells you where you are today. A trend tells you whether your risk is growing, shrinking, or holding steady.

For most people, the useful cadence is: get a baseline now, retest in 6 to 12 months if you are actively avoiding scallops and want to see whether levels are dropping, and retest annually thereafter if the number matters for your food decisions. If you are pursuing oral immunotherapy or another intervention, testing at 3 to 6 month intervals makes more sense. In shrimp-allergic children, epitope recognition patterns weaken with age, which is one reason serial testing matters.

What to Do With an Elevated Result

A positive scallop IgE result alongside a convincing reaction history is enough to justify avoidance. A positive result without a reaction history is the ambiguous case. Here is how to think about next steps:

  • Order companion shellfish IgE tests: shrimp IgE and other mollusk-specific tests help define whether this is an isolated scallop signal or part of a broader shellfish pattern.
  • Consider component-resolved diagnostics: IgE tests against specific shellfish proteins like tropomyosin (for example, Pen a 1 in shrimp) can sharpen the picture. Higher tropomyosin IgE is associated with more severe and more cross-reactive shellfish disease.
  • See an allergist before deciding: a board-certified allergist can integrate your history, skin prick testing, and serum IgE results, and determine whether a supervised oral food challenge is appropriate. The oral food challenge remains the reference standard when history and blood tests disagree.
  • Do not stop eating scallops based on a borderline number alone: if you have been eating them without symptoms, a low positive is more likely cross-reactivity than true allergy. Confirm before restricting your diet.

If you have never eaten scallops and your IgE is elevated, that is a different conversation. A formal evaluation before a first exposure is worth the caution.

What Moves This Biomarker

Evidence-backed interventions that affect your Scallop IgE level

Decrease
Omalizumab (anti-IgE biologic therapy)
Omalizumab is an injectable biologic that binds free IgE antibodies in your blood. In a randomized trial of 180 people with multiple food allergies, 16 weeks of omalizumab raised the reaction threshold for peanut and other common food allergens compared with placebo. The trial did not specifically measure scallop IgE, so the effect on scallop-specific IgE has not been directly shown. Omalizumab reduces overall IgE-mediated reactivity rather than treating scallop allergy specifically.
MedicationStrong Evidence
Decrease
Oral immunotherapy for shellfish allergy
Oral immunotherapy gradually trains your immune system to tolerate a food by exposing you to escalating doses under medical supervision. In a phase 2 trial of shrimp oral immunotherapy in 12 shrimp-allergic participants, most achieved sustained unresponsiveness after 6 weeks of maintenance and then avoidance. The trial measured shrimp-specific IgE rather than scallop IgE specifically, so the effect on scallop IgE has not been directly demonstrated in this trial.
MedicationModerate Evidence
Decrease
Sublingual immunotherapy for shrimp allergy
Sublingual immunotherapy delivers small doses of allergen under the tongue over months to years. A nine-year observational experience with 66 shrimp-allergic patients in a Midwest allergy-immunology practice found this approach safely desensitized many patients, with some achieving sustained tolerance after regular exposure. The study tracked shrimp-specific IgE, not scallop-specific IgE, so evidence about scallop IgE specifically is indirect.
MedicationModerate Evidence

Frequently Asked Questions

References

19 studies
  1. Tsabouri S, Triga M, Makris M, Kalogeromitros D, Church M, Priftis KPediatric Allergy and Immunology2012
  2. Pedrosa M, Boyano-martínez T, García-ara C, Quirce SClinical Reviews in Allergy & Immunology2015
  3. Ayuso R, Sánchez-garcía S, Lin J, Fu Z, Ibáñez M, Carrillo T, Blanco C, Goldis M, Bardina L, Sastre J, Sampson HThe Journal of Allergy and Clinical Immunology2010
  4. Matsuo H, Yokooji T, Taogoshi TAllergology International2015
  5. Scala E, Abeni D, Aruanno a, Boni E, Brusca I, Cappiello F, Caprini E, Buzzulini F, Deleonardi G, Demonte a, Farioli LThe World Allergy Organization Journal2022